Name
Lecture: Unleashing anticancer T cells - is strength in numbers enough?
Date & Time
Tuesday, April 30, 2019, 8:30 AM - 9:30 AM
Matthew Atherton
Description

• Understand how next-generation recombinant technologies are designed to improve patient outcomes.
• Understand the processes of expanding and engineering autologous T cells ex vivo alongside the current and future applications of CAR T cells in the veterinary oncology clinic.
• Recognize the barriers to tumor specific T cells and how future therapeutic strategies must be developed to overcome immunoevasive mechanisms.